
#32 Hidden Virus, Immune Exhaustion & the Brain: Long Covid, ME/CFS and post-viral illness with Dr Avindra Nath (NIH)
Episode 32
SCIENCE: Long Covid | ME/CFS | Neuroinflammation | Clinical Trials What happens to the brain when a virus takes hold and why do some people never fully recover? Dr Avindra Nath has spent his career at the intersection of neurology and infectious disease, from the early AIDS pandemic through Zika and Ebola to today's work on Long COVID and ME/CFS. As Clinical Director of the NIH's National Institute of Neurological Disorders and Stroke (NINDS), he is leading some of the most important research into post-viral illness happening anywhere in the world. In this episode, Dr. Nath explains the neuroscience of viral infection in accessible terms: how viruses enter and adapt inside the brain, how a single infected cell can trigger widespread neurological dysfunction, and why viral remnants (fragments of protein and RNA that linger long after the acute infection) may be enough on their own to cause ongoing damage. He shares the key findings from the NIH's landmark 2024 deep-phenotyping study of post-infectious ME/CFS patients, including: Persistent immune activation and immune exhaustion, even years after infection Striking sex differences in immune response: B cell activation dominant in men, T cell activation in women. with major implications for treatment Why cohort selection and subtyping matter when designing therapies Why a one-size-fits-all treatment approach will not work Dr.
Publisher
Make Visible: ME/CFS, Long Covid, POTS, EDS, Fibro & MCAS Explored
Link
madevisible.podbean.com/e/32-viral-remnants-immune-exhaustion-and-the-brain-whats-really-happening-in-long-covid-and-mecfs-with-dr-avindra-nath-nih/
Published
April 24, 2026
Duration
58 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Visible with Emily Kate Stephens
Make Visible: ME/CFS, Long Covid, POTS, EDS, Fibro & MCAS Explored
@makevisiblemecfslongcovidpot
#immuneexhaustion #viralillness #dravindranath #medicine
